Henry Schein (HSIC) EBITDA (2009 - 2026)
Henry Schein (HSIC) EBITDA from Jun 27, 2009 to Mar 28, 2026. The TTM Henry Schein (HSIC) EBITDA is $979M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Henry Schein (HSIC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +33.66% |
| 3 Years TTM | +22.96% |
| 5 Years TTM | +9.51% |
| 10 Years TTM | +3.01% |
| All Time TTM | +7.72% |
Annual EBITDA change of Henry Schein (HSIC)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $263M | -72.72% |
| 2025 | $964M | +5.01% |
| 2024 | $918M | +6.37% |
| 2023 | $863M | -10.01% |
| 2022 | $959M | -9.70% |
| 2021 | $1.06B | +47.30% |
| 2020 | $721M | -20.17% |
| 2019 | $903M | +21.36% |
| 2018 | $744M | -7.39% |
| 2017 | $804M | -14.63% |
| 2016 | $941M | +5.40% |
| 2015 | $893M | +2.97% |
| 2014 | $867M | +7.74% |
| 2013 | $805M | +8.17% |
| 2012 | $744M | +6.62% |
| 2011 | $698M | +12.16% |
| 2010 | $622M | +14.07% |
| 2009 | $546M | +9.68% |
| 2008 | $497M | N/A |
Comparison Henry Schein (HSIC) five years EBITDA CAGR with competitors
Henry Schein (HSIC) five years EBITDA CAGR is 4.67%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| AHG | Akso Health Group | 27.89% | +496.87% |
| CAH | Cardinal Health Inc | 15.33% | +228.16% |